Ranlu Liu

1.0k total citations
57 papers, 775 citations indexed

About

Ranlu Liu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Ranlu Liu has authored 57 papers receiving a total of 775 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 28 papers in Pulmonary and Respiratory Medicine and 12 papers in Cancer Research. Recurrent topics in Ranlu Liu's work include Prostate Cancer Treatment and Research (18 papers), Prostate Cancer Diagnosis and Treatment (9 papers) and RNA Interference and Gene Delivery (7 papers). Ranlu Liu is often cited by papers focused on Prostate Cancer Treatment and Research (18 papers), Prostate Cancer Diagnosis and Treatment (9 papers) and RNA Interference and Gene Delivery (7 papers). Ranlu Liu collaborates with scholars based in China, Canada and United States. Ranlu Liu's co-authors include Yong Xu, Hongtuan Zhang, Zhihong Zhang, Shiyong Qi, Andi Wang, Jing Li, Tao Zhang, Yuzhuo Wang, Jia Guo and Pan Pan and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Medicine.

In The Last Decade

Ranlu Liu

57 papers receiving 765 citations

Peers

Ranlu Liu
Maria Teresa Landi United States
Yidong Fan China
Xiaoming Hou China
Qilin Ao China
Angelina Di Carlo Italy
Yunyan Wang China
Xiao Sun China
Amin El‐Heliebi Austria
Sanyuan Sun China
Ting‐Ying Fu Taiwan
Maria Teresa Landi United States
Ranlu Liu
Citations per year, relative to Ranlu Liu Ranlu Liu (= 1×) peers Maria Teresa Landi

Countries citing papers authored by Ranlu Liu

Since Specialization
Citations

This map shows the geographic impact of Ranlu Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ranlu Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ranlu Liu more than expected).

Fields of papers citing papers by Ranlu Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ranlu Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ranlu Liu. The network helps show where Ranlu Liu may publish in the future.

Co-authorship network of co-authors of Ranlu Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Ranlu Liu. A scholar is included among the top collaborators of Ranlu Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ranlu Liu. Ranlu Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Liu, Dongze, Qin Zheng, Hongbo Xie, et al.. (2023). Experimental validation and pan-cancer analysis identified COL10A1 as a novel oncogene and potential therapeutic target in prostate cancer. Aging. 15(24). 15134–15160. 5 indexed citations
4.
Liu, Dongze, et al.. (2023). Anoikis-related gene signature as novel prognostic biomarker to predict immunotherapy with bladder urothelial carcinoma. ONCOLOGIE. 25(3). 291–308. 2 indexed citations
5.
Jiang, Yuchen, et al.. (2023). MicroRNA-367-3p directly targets RAB23 and inhibits proliferation, migration and invasion of bladder cancer cells and increases cisplatin sensitivity. Journal of Cancer Research and Clinical Oncology. 149(20). 17807–17821. 5 indexed citations
6.
Sun, Guangyu, et al.. (2022). Multi-omics analysis of expression and prognostic value of NSUN members in prostate cancer. Frontiers in Oncology. 12. 965571–965571. 25 indexed citations
7.
8.
Liu, Ranlu, et al.. (2020). Impact of positive surgical margin location and perineural invasion on biochemical recurrence in patients undergoing radical prostatectomy. World Journal of Surgical Oncology. 18(1). 201–201. 13 indexed citations
9.
Liu, Ranlu, et al.. (2019). The impact of PTEN deletion and ERG rearrangement on recurrence after treatment for prostate cancer: a systematic review and meta-analysis. Clinical & Translational Oncology. 22(5). 694–702. 12 indexed citations
10.
Li, Tao, et al.. (2019). Association between male pattern baldness and testicular germ cell tumor: a meta-analysis. BMC Cancer. 19(1). 53–53. 2 indexed citations
11.
Lü, Chao, Changli Wu, Zhihong Zhang, et al.. (2018). Selective Actionable and Druggable Protein Kinases Drive the Progression of Neuroendocrine Prostate Cancer. DNA and Cell Biology. 37(9). 758–766. 2 indexed citations
12.
Liu, Yan, et al.. (2017). Cripto-1 promotes epithelial-mesenchymal transition in prostate cancer via Wnt/β-catenin signaling. Oncology Reports. 37(3). 1521–1528. 24 indexed citations
13.
Li, Yalin, Pan Pan, Pengfei Qiao, & Ranlu Liu. (2015). Downregulation of N-myc downstream regulated gene 1 caused by the methylation of CpG islands of NDRG1 promoter promotes proliferation and invasion of prostate cancer cells. International Journal of Oncology. 47(3). 1001–1008. 23 indexed citations
14.
Yang, Kuo, Chao Meng, Yong Xu, et al.. (2012). Expression and significance of vasculogenic mimicry and matrix metalloproteinase-2 in prostate cancer. Zhonghua miniao waike zazhi. 33(10). 791–794. 1 indexed citations
15.
Zhang, Hongtuan, et al.. (2012). The Interleukin-6 –174G/C Polymorphism and Prostate Cancer Risk: A Systematic Review and Meta-Analysis. Urologia Internationalis. 88(4). 447–453. 20 indexed citations
16.
Mu, Yi, et al.. (2012). Moxifloxacin monotherapy for treatment of complicated intra-abdominal infections: a meta-analysis of randomised controlled trials. International Journal of Clinical Practice. 66(2). 210–217. 8 indexed citations
17.
Liu, Ranlu, et al.. (2012). Evaluation of acridine orange florescence in exfoliative urinary cytology for diagnosing bladder carcinoma. International Urology and Nephrology. 44(5). 1375–1382. 7 indexed citations
18.
Chen, Yue, Gang Wang, Deling Kong, et al.. (2012). In vitro and in vivo double-enhanced suicide gene therapy mediated by generation 5 polyamidoamine dendrimers for PC-3 cell line. World Journal of Surgical Oncology. 10(1). 3–3. 8 indexed citations
19.
Zhang, Hongtuan, Yong Xu, Zhihong Zhang, Ranlu Liu, & Baojie Ma. (2012). Association between COX-2 rs2745557 polymorphism and prostate cancer risk: a systematic review and meta-analysis. BMC Immunology. 13(1). 14–14. 35 indexed citations
20.
Zhang, Zhihong, Xiaolei Guo, Baojie Ma, et al.. (2009). Prevalence of benign prostate hyperplasia and its relative factors in rural areas of Tianjin in 2008. Zhonghua miniao waike zazhi. 30(11). 761–764. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria Teresa Landi Breakdown of academic impact, for papers by Yidong Fan Breakdown of academic impact, for papers by Xiaoming Hou Breakdown of academic impact, for papers by Qilin Ao Breakdown of academic impact, for papers by Angelina Di Carlo Breakdown of academic impact, for papers by Yunyan Wang Breakdown of academic impact, for papers by Xiao Sun Breakdown of academic impact, for papers by Amin El‐Heliebi Breakdown of academic impact, for papers by Sanyuan Sun Breakdown of academic impact, for papers by Ting‐Ying Fu
Rankless by CCL
2026